Fairvalue-Calculator Fairvalue-Calculator
EN DE

Baird Medical Investment Holdings (BDMD) Fair Value & Analysis

Healthcare · US · Market cap $37.1M

Price$1.02
Fair Value$0.5200
Upside-49.0%
Quality95/100
Evidence: Low Range $0.3400 – $0.6500

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Baird Medical Investment Holdings (BDMD) currently trades at $1.02, while our model-based Fair Value estimate is $0.5200 — implying the stock looks roughly 49.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is Baird Medical Investment Holdings (BDMD) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.5200 versus a price of $1.02 — about −49% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BDMD?
Our 21-model fair value for Baird Medical Investment Holdings is $0.5200 (as of Jun 25, 2026), built from audited fundamentals. The current price is $1.02.
What is the quality score of BDMD?
Baird Medical Investment Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.